{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:45:17Z","timestamp":1785437117511,"version":"3.56.0"},"posted":{"date-parts":[[2026,7,28]]},"group-title":"Systems Biology","reference-count":54,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["P41 GM108538"],"award-info":[{"award-number":["P41 GM108538"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["5 T32 GM13506"],"award-info":[{"award-number":["5 T32 GM13506"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["P30 DK5634"],"award-info":[{"award-number":["P30 DK5634"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/02s376052","id-type":"ROR","asserted-by":"publisher"}]},{"award":["ERC-AdG-787702"],"award-info":[{"award-number":["ERC-AdG-787702"]}],"id":[{"id":"https:\/\/ror.org\/0472cxd90","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["31003A-179435"],"award-info":[{"award-number":["31003A-179435"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030-214826"],"award-info":[{"award-number":["310030-214826"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swiss Cancer League","award":["KLS-5906-08-2023"],"award-info":[{"award-number":["KLS-5906-08-2023"]}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>The limited treatment options available for the estimated 38% of adults worldwide affected by Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) are largely due to an incomplete understanding of the complex molecular networks underlying disease pathogenesis. To dissect the genetic architecture and proteomic regulation underlying MASLD, we generated a genetically diverse mouse cohort through a four-way cross of founder strains with varying susceptibility to liver disease, producing 444 F2 mice with a spectrum of phenotypes and genotypes. Utilizing deep proteomic profiling of the livers of this population, we identified quantitative trait loci (QTL) for 2,652 proteins, spanning over 4,000 unique genomic loci, and distinguished cis- and trans-acting regulatory mechanisms. Integrating proteomic, genomic, and phenotypic data reveals key regulatory loci and candidate proteins influencing disease progression, creating a mineable proteogenomic resource for MASLD research. We utilize this resource to identify the E3 ubiquitin ligase Ubr1 as a candidate central regulator connecting proteostasis and lipid metabolism, with genetic polymorphisms that may alter its abundance and predispose to metabolic dysfunction. This study demonstrates how high-throughput, deep proteome profiling integrated with QTL mapping can reveal complex gene-protein networks governing MASLD susceptibility and progression, offering novel insights for biomarker discovery and therapeutic targeting.<\/jats:p>","DOI":"10.64898\/2026.07.26.740836","type":"posted-content","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:05:19Z","timestamp":1785233119000},"source":"Crossref","is-referenced-by-count":0,"title":["Proteome-wide QTL mapping enables gene-protein-phenotype metabolic network construction in a genetically diverse MASLD mouse model"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-3770","authenticated-orcid":false,"given":"Margaret Lea","family":"Robinson","sequence":"first","affiliation":[{"name":"Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Systems Physiology, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Benegiamo","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Systems Physiology, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miller T.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon I.","family":"Smith","sequence":"additional","affiliation":[{"name":"School of Medicine, Washington University in St Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Klein","sequence":"additional","affiliation":[{"name":"School of Medicine, Washington University in St Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Auwerx","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Systems Physiology, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J","family":"Coon","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, USA"},{"name":"Morgridge Institute for Research, Madison, WI"},{"name":"National Center for Quantitative Biology of Complex Systems, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026073003101242000_2026.07.26.740836v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1964"},{"key":"2026073003101242000_2026.07.26.740836v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"2026073003101242000_2026.07.26.740836v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109"},{"key":"2026073003101242000_2026.07.26.740836v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.41"},{"key":"2026073003101242000_2026.07.26.740836v1.5","doi-asserted-by":"crossref","unstructured":"Takawy, M. W. & Abdelmalek, M. F . Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis. Curr Diab Rep 25, 23 (2025).","DOI":"10.1007\/s11892-025-01579-1"},{"key":"2026073003101242000_2026.07.26.740836v1.6","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1097\/CM9.0000000000003355","article-title":"Drug treatment for metabolic dysfunction-associated steatotic liver disease: Progress and direction","volume":"137","year":"2024","journal-title":"Chin Med J (Engl"},{"key":"2026073003101242000_2026.07.26.740836v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413258"},{"key":"2026073003101242000_2026.07.26.740836v1.8","doi-asserted-by":"crossref","unstructured":"Suvarna, R. , Shetty, S. & Pappachan, J. M . Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-\u03b2 agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Sci Rep 14, 19790 (2024).","DOI":"10.1038\/s41598-024-70242-8"},{"key":"2026073003101242000_2026.07.26.740836v1.9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5009\/gnl240407","article-title":"Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"19","year":"2025","journal-title":"Gut Liver"},{"key":"2026073003101242000_2026.07.26.740836v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.02.033"},{"key":"2026073003101242000_2026.07.26.740836v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2017.06.007"},{"key":"2026073003101242000_2026.07.26.740836v1.12","doi-asserted-by":"crossref","unstructured":"Benegiamo, G. et al. The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression. J Exp Med 220, (2023).","DOI":"10.1084\/jem.20221738"},{"key":"2026073003101242000_2026.07.26.740836v1.13","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.111.132597"},{"key":"2026073003101242000_2026.07.26.740836v1.14","unstructured":"Broman, K. W. & Sen, S . A Guide to QTL Mapping with R\/qtl. (Springer, 2011)."},{"key":"2026073003101242000_2026.07.26.740836v1.15","unstructured":"Wu, R. , Ma, C. & Casella, G . Statistical Genetics of Quantitative Traits: Linkage, Maps and QTL. (Springer, 2010)."},{"key":"2026073003101242000_2026.07.26.740836v1.16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cels.2020.10.005","article-title":"Proteome-wide Systems Genetics to Identify Functional Regulators of Complex Traits","volume":"12","year":"2021","journal-title":"Cell Syst"},{"key":"2026073003101242000_2026.07.26.740836v1.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaq1327"},{"key":"2026073003101242000_2026.07.26.740836v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0175-2"},{"key":"2026073003101242000_2026.07.26.740836v1.19","doi-asserted-by":"crossref","unstructured":"Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun 8, 14357 (2017).","DOI":"10.1038\/ncomms15345"},{"key":"2026073003101242000_2026.07.26.740836v1.20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c04497"},{"key":"2026073003101242000_2026.07.26.740836v1.21","doi-asserted-by":"crossref","unstructured":"Serrano, L. R. et al. The One Hour Human Proteome. Mol Cell Proteomics 23, 100760 (2024).","DOI":"10.1016\/j.mcpro.2024.100760"},{"key":"2026073003101242000_2026.07.26.740836v1.22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c02856"},{"key":"2026073003101242000_2026.07.26.740836v1.23","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JPROTEOME.3C00357"},{"key":"2026073003101242000_2026.07.26.740836v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-02099-7"},{"key":"2026073003101242000_2026.07.26.740836v1.25","doi-asserted-by":"crossref","unstructured":"Lou, R. et al. Benchmarking commonly used software suites and analysis workflows for DIA proteomics and phosphoproteomics. Nat Commun 14, 94 (2023).","DOI":"10.1038\/s41467-022-35740-1"},{"key":"2026073003101242000_2026.07.26.740836v1.26","unstructured":"Benegiamo, G. , et al. A novel mouse cross uncovers candidate therapeutic targets for hepatic steatosis, adiposity, and dyslipidemia. under review (2026)."},{"key":"2026073003101242000_2026.07.26.740836v1.27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/apt.18468","article-title":"The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions","volume":"61","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"2026073003101242000_2026.07.26.740836v1.28","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis 23, 117 (2024).","DOI":"10.1186\/s12944-024-02108-x"},{"key":"2026073003101242000_2026.07.26.740836v1.29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i29.6742"},{"key":"2026073003101242000_2026.07.26.740836v1.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-025-02535-y"},{"key":"2026073003101242000_2026.07.26.740836v1.31","doi-asserted-by":"publisher","DOI":"10.3390\/biom5032140"},{"key":"2026073003101242000_2026.07.26.740836v1.32","doi-asserted-by":"crossref","first-page":"3574261","DOI":"10.1155\/2020\/3574261","article-title":"Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma","volume":"2020","year":"2020","journal-title":"Biomed Res Int"},{"key":"2026073003101242000_2026.07.26.740836v1.33","doi-asserted-by":"crossref","unstructured":"Shen, Z. et al. The EZH2\/MCM Complex\/hTERT axis facilitates hepatocellular carcinoma progression by inhibiting cellular senescence. Mech Ageing Dev 224, 112040 (2025).","DOI":"10.1016\/j.mad.2025.112040"},{"key":"2026073003101242000_2026.07.26.740836v1.34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12072-021-10200-y","article-title":"Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.","volume":"15","year":"2021","journal-title":"Hepatol Int"},{"key":"2026073003101242000_2026.07.26.740836v1.35","doi-asserted-by":"crossref","first-page":"e1004818","DOI":"10.1371\/journal.pgen.1004818","article-title":"Mediation analysis demonstrates that trans-eQTLs are often explained by cis-mediation: a genome-wide analysis among 1,800 South Asians","volume":"10","year":"2014","journal-title":"PLoS Genet"},{"key":"2026073003101242000_2026.07.26.740836v1.36","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/jcsm.13233","article-title":"Identification of Ubr1 as an amino acid sensor of steatosis in liver and muscle","volume":"14","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026073003101242000_2026.07.26.740836v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.01.021"},{"key":"2026073003101242000_2026.07.26.740836v1.38","doi-asserted-by":"crossref","unstructured":"Jin, Y. , Ren, Z. , Tan, Y. , Zhao, P. & Wu, J . Motility Plays an Important Role in the Lifetime of Mammalian Lipid Droplets. Int J Mol Sci 22, (2021).","DOI":"10.3390\/ijms22083802"},{"key":"2026073003101242000_2026.07.26.740836v1.39","first-page":"159610","article-title":"Cytoskeleton regulates lipid droplet fusion and lipid storage by controlling lipid droplet movement","volume":"1870","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2026073003101242000_2026.07.26.740836v1.40","doi-asserted-by":"crossref","unstructured":"Singh, J. , Sanghavi, P. & Mallik, R . Microtubule motor driven interactions of lipid droplets: Specificities and opportunities. Front Cell Dev Biol 10, 893375 (2022).","DOI":"10.3389\/fcell.2022.893375"},{"key":"2026073003101242000_2026.07.26.740836v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2019.08.013"},{"key":"2026073003101242000_2026.07.26.740836v1.42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00226.2010"},{"key":"2026073003101242000_2026.07.26.740836v1.43","doi-asserted-by":"crossref","unstructured":"Udeshi, N. D. et al. Rapid and deep-scale ubiquitylation profiling for biology and translational research. Nat Commun 11, 359 (2020).","DOI":"10.1038\/s41467-019-14175-1"},{"key":"2026073003101242000_2026.07.26.740836v1.44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304928110"},{"key":"2026073003101242000_2026.07.26.740836v1.45","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E10-02-0098"},{"key":"2026073003101242000_2026.07.26.740836v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2121"},{"key":"2026073003101242000_2026.07.26.740836v1.47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807616200"},{"key":"2026073003101242000_2026.07.26.740836v1.48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1113\/EP092535","article-title":"Hydroxysteroid 17\u03b2-dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice","volume":"110","year":"2025","journal-title":"Exp Physiol"},{"key":"2026073003101242000_2026.07.26.740836v1.49","doi-asserted-by":"crossref","unstructured":"Iturbe-Rey, S. et al. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis 400, 119053 (2025).","DOI":"10.1016\/j.atherosclerosis.2024.119053"},{"key":"2026073003101242000_2026.07.26.740836v1.50","doi-asserted-by":"crossref","unstructured":"Bai, W. & Zhu, Z . Multiorgan crosstalk in MASLD\/MASH: from hepatic pathogenesis to systemic complications. Front Endocrinol (Lausanne ) 16, 1720780 (2025).","DOI":"10.3389\/fendo.2025.1720780"},{"key":"2026073003101242000_2026.07.26.740836v1.51","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.14.682191"},{"key":"2026073003101242000_2026.07.26.740836v1.52","doi-asserted-by":"crossref","unstructured":"Kumar, M. et al. Expanding the Global Map of Protein Post Translational Modifications with Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass Spectrometer. Mol Cell Proteomics 101562 (2026).","DOI":"10.1016\/j.mcpro.2026.101562"},{"key":"2026073003101242000_2026.07.26.740836v1.53","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.8b02766"},{"key":"2026073003101242000_2026.07.26.740836v1.54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.07.26.740836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:10:22Z","timestamp":1785406222000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.07.26.740836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":54,"URL":"https:\/\/doi.org\/10.64898\/2026.07.26.740836","relation":{},"subject":[],"published":{"date-parts":[[2026,7,28]]},"subtype":"preprint"}}